By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cytokinetics, Inc. 

280 East Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-624-3000 Fax: 650-624-3010


Drug Discovery

Company News
Cytokinetics (CYTK) Announces Baseline Data From First Cohort Of Phase II Clinical Trial Of CK-2127107 In Patients With SMA 7/5/2017 9:03:24 AM
Cytokinetics (CYTK) Announces Orphan Drug Designation For CK-2127107 For The Treatment Of Spinal Muscular Atrophy 5/15/2017 7:10:49 AM
Cytokinetics (CYTK) To Hold Annual Meeting Of Stockholders 5/12/2017 7:45:45 AM
Cytokinetics (CYTK) Announces Pricing Of Public Offering Of Common Stock 5/9/2017 10:17:58 AM
Cytokinetics (CYTK) Announces Results From Dose Escalation Phase Of COSMIC-HF Presented At Heart Failure 2017 5/1/2017 8:24:24 AM
Cytokinetics (CYTK) Reports First Quarter 2017 Financial Results 4/28/2017 11:07:36 AM
Cytokinetics (CYTK) Added To S&P SmallCap 600 4/24/2017 8:15:22 AM
Cytokinetics (CYTK) To Announce First Quarter Results On April 27, 2017 4/14/2017 11:05:55 AM
Cytokinetics (CYTK) Announces Preclinical Data For CK-2127107 Presented At MDA Scientific Conference 3/22/2017 8:46:06 AM
Cytokinetics (CYTK) Announces Additional Results From COSMIC-HF Presented At American College of Cardiology.17 3/20/2017 8:10:09 AM